Cargando…
The effect of intraperitoneal administration of BromAc on blood parameters: phase 1 study
Intraperitoneal administration of BromAc (bromelain + acetylcysteine) is currently undergoing a phase 1 clinical trial for pseudomyxoma peritonei at our institution. This study reports on analysis of routine blood parameters before and after treatment for a series of 25 patients in this trial. Blood...
Autores principales: | Ke, Kevin, Pillai, Krishna, Mekkawy, Ahmed H., Akhter, Javed, Badar, Samina, Valle, Sarah J., Morris, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777505/ https://www.ncbi.nlm.nih.gov/pubmed/35201475 http://dx.doi.org/10.1007/s12672-021-00418-5 |
Ejemplares similares
-
Intraperitoneal BromAc(®) Does Not Interfere with the Healing of Colon Anastomosis
por: Mekkawy, Ahmed H., et al.
Publicado: (2023) -
The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2
por: Akhter, Javed, et al.
Publicado: (2021) -
Effect of Nebulized BromAc on Rheology of Artificial Sputum: Relevance to Muco-Obstructive Respiratory Diseases
por: Pillai, Krishna, et al.
Publicado: (2023) -
Novel Use of Bromelain and Acetylcysteine (BromAc®) for Pleural Involvement in Pseudomyxoma Peritonei
por: Lam, Anthony R., et al.
Publicado: (2021) -
Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19
por: Coelho dos Reis, Jordana Grazziela A., et al.
Publicado: (2022)